BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 23786849)

  • 1. Cyclin D1 cooperates with p21 to regulate TGFβ-mediated breast cancer cell migration and tumor local invasion.
    Dai M; Al-Odaini AA; Fils-Aimé N; Villatoro MA; Guo J; Arakelian A; Rabbani SA; Ali S; Lebrun JJ
    Breast Cancer Res; 2013 Jun; 15(3):R49. PubMed ID: 23786849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFβ-mediated breast cancer cell migration and invasion.
    Dai M; Al-Odaini AA; Arakelian A; Rabbani SA; Ali S; Lebrun JJ
    Breast Cancer Res; 2012 Sep; 14(5):R127. PubMed ID: 22995475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KiSS1 gene as a novel mediator of TGFβ-mediated cell invasion in triple negative breast cancer.
    Tian J; Al-Odaini AA; Wang Y; Korah J; Dai M; Xiao L; Ali S; Lebrun JJ
    Cell Signal; 2018 Jan; 42():1-10. PubMed ID: 28988968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The leukemia inhibitory factor (LIF) and p21 mediate the TGFβ tumor suppressive effects in human cutaneous melanoma.
    Humbert L; Ghozlan M; Canaff L; Tian J; Lebrun JJ
    BMC Cancer; 2015 Mar; 15():200. PubMed ID: 25885043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor-interacting protein kinase 2 promotes triple-negative breast cancer cell migration and invasion via activation of nuclear factor-kappaB and c-Jun N-terminal kinase pathways.
    Singel SM; Batten K; Cornelius C; Jia G; Fasciani G; Barron SL; Wright WE; Shay JW
    Breast Cancer Res; 2014 Mar; 16(2):R28. PubMed ID: 24642040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer.
    Cheng G; Fan X; Hao M; Wang J; Zhou X; Sun X
    Mol Cancer; 2016 Apr; 15(1):30. PubMed ID: 27130446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heregulin beta1 promotes breast cancer cell proliferation through Rac/ERK-dependent induction of cyclin D1 and p21Cip1.
    Yang C; Klein EA; Assoian RK; Kazanietz MG
    Biochem J; 2008 Feb; 410(1):167-75. PubMed ID: 17941827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a natural small-molecule compound that suppresses tumor EMT, stemness and metastasis by inhibiting TGFβ/BMP signaling in triple-negative breast cancer.
    Di L; Liu LJ; Yan YM; Fu R; Li Y; Xu Y; Cheng YX; Wu ZQ
    J Exp Clin Cancer Res; 2019 Mar; 38(1):134. PubMed ID: 30898152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin D1 degradation and p21 induction contribute to growth inhibition of colorectal cancer cells induced by epigallocatechin-3-gallate.
    Zhang X; Min KW; Wimalasena J; Baek SJ
    J Cancer Res Clin Oncol; 2012 Dec; 138(12):2051-60. PubMed ID: 22814742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The circular RNA circEIF3M promotes breast cancer progression by promoting cyclin D1 expression.
    Li X; Ren Z; Yao Y; Bao J; Yu Q
    Aging (Albany NY); 2020 Jul; 12(14):14775-14790. PubMed ID: 32652519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
    Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
    Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFITM1 suppression blocks proliferation and invasion of aromatase inhibitor-resistant breast cancer in vivo by JAK/STAT-mediated induction of p21.
    Lui AJ; Geanes ES; Ogony J; Behbod F; Marquess J; Valdez K; Jewell W; Tawfik O; Lewis-Wambi J
    Cancer Lett; 2017 Jul; 399():29-43. PubMed ID: 28411130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of estradiol and medroxyprogesterone acetate on expression of the cell cycle proteins cyclin D1, p21 and p27 in cultured human breast tissues.
    Eigeliene N; Härkönen P; Erkkola R
    Cell Cycle; 2008 Jan; 7(1):71-80. PubMed ID: 18196959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRMT2 and RORγ expression are associated with breast cancer survival outcomes.
    Oh TG; Bailey P; Dray E; Smith AG; Goode J; Eriksson N; Funder JW; Fuller PJ; Simpson ER; Tilley WD; Leedman PJ; Clarke CL; Grimmond S; Dowhan DH; Muscat GE
    Mol Endocrinol; 2014 Jul; 28(7):1166-85. PubMed ID: 24911119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin D1, Id1 and EMT in breast cancer.
    Tobin NP; Sims AH; Lundgren KL; Lehn S; Landberg G
    BMC Cancer; 2011 Sep; 11():417. PubMed ID: 21955753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of ILK inhibits glioma development via upregulation of E-cadherin and downregulation of cyclin D1.
    Zheng K; Wang G; Li C; Shan X; Liu H
    Oncol Rep; 2015 Jul; 34(1):272-8. PubMed ID: 25998224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GATA3 transcription factor abrogates Smad4 transcription factor-mediated fascin overexpression, invadopodium formation, and breast cancer cell invasion.
    Sun J; He H; Pillai S; Xiong Y; Challa S; Xu L; Chellappan S; Yang S
    J Biol Chem; 2013 Dec; 288(52):36971-82. PubMed ID: 24235142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profilin 2 (PFN2) promotes the proliferation, migration, invasion and epithelial-to-mesenchymal transition of triple negative breast cancer cells.
    Ling Y; Cao Q; Liu Y; Zhao J; Zhao Y; Li K; Chen Z; Du X; Huo X; Kang H; Chen Z
    Breast Cancer; 2021 Mar; 28(2):368-378. PubMed ID: 33047272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Miz-1 promotes the proliferation of esophageal cancer cells via suppression of p21 and release of p21-arrested cyclin D1.
    Luo J; Zhang C; Wang C; Li L; Li C; Li Q; Zhang M; Wu Q
    Oncol Rep; 2016 Jun; 35(6):3532-40. PubMed ID: 27109891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of CDK-mediated Smad3 phosphorylation reduces the Pin1-Smad3 interaction and aggressiveness of triple negative breast cancer cells.
    Thomas AL; Lind H; Hong A; Dokic D; Oppat K; Rosenthal E; Guo A; Thomas A; Hamden R; Jeruss JS
    Cell Cycle; 2017 Aug; 16(15):1453-1464. PubMed ID: 28678584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.